The Atherogenic Dyslipidemia of Metabolic Syndrome: An Update on the Role of Niacin

LIPIDS OCCUPY A DISTINGUISHED PLACE as a modifiable vascular risk factor. Over the last 40 years, in countries where a significant reduction in atherosclerotic cardiovascular disease (ASCVD) was found the primary contributions came from reductions in lipids, blood pressure, and smoking rates. Both total cholesterol (TC) and LDL cholesterol (LDL-C) are considered “the most important independent predictors of cardiovascular morbidity and mortality.”